TGFB2 and breast carcinoma: In the bone marrow niche, mesenchymal stem cells (MSCs) induce breast cancer cell dormancy by secreting transforming growth factor-β2 (TGF-β2) and bone morphogenetic protein 7 (BMP7), which activate the TGFBRIII/BMPRII-p38-p27 pathway.